Selected research
Market Structure
Global Diabetic Retinopathy Screening Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Diabetic Retinopathy Screening Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Diabetic Retinopathy Screening Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Diabetic Retinopathy Screening Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Diabetic Retinopathy Screening Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Diabetic Retinopathy Screening Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Diabetic Retinopathy Screening Solution include RETINA-AI Health, IRIS, Retina Labs, CheckEye, RetinaLyze, NEC Software, InHealth Intelligence, RetinaRisk and Thirona Retina, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Diabetic Retinopathy Screening Solution market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Diabetic Retinopathy Screening Solution and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Diabetic Retinopathy Screening Solution revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Diabetic Retinopathy Screening Solution market size, projected growth trends, production technologies, key applications, and end-use industries.
Diabetic Retinopathy Screening Solution Segment by Company
RETINA-AI Health
IRIS
Retina Labs
CheckEye
RetinaLyze
NEC Software
InHealth Intelligence
RetinaRisk
Thirona Retina
Synapxe
Eyenuk
EyRIS (SELENA+)
Vistel
Diabetic Retinopathy Screening Solution Segment by Type
Traditional
Artificial Intelligence
Others
Diabetic Retinopathy Screening Solution Segment by Application
Medical Industry
Scientific Research
Others
Diabetic Retinopathy Screening Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diabetic Retinopathy Screening Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diabetic Retinopathy Screening Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diabetic Retinopathy Screening Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Diabetic Retinopathy Screening Solution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Diabetic Retinopathy Screening Solution industry.
Chapter 3: Detailed analysis of Diabetic Retinopathy Screening Solution companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetic Retinopathy Screening Solutionrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Traditional
- Artificial Intelligence
- Others
Applications
- Medical Industry
- Scientific Research
- Others
Companies covered
- RETINA-AI Health
- IRIS
- Retina Labs
- CheckEye
- RetinaLyze
- NEC Software
- InHealth Intelligence
- RetinaRisk
- Thirona Retina
- Synapxe
- Eyenuk
- EyRIS (SELENA+)
- Vistel
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Diabetic Retinopathy Screening Solution Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Traditional
- 1.2.3 Artificial Intelligence
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Diabetic Retinopathy Screening Solution Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Medical Industry
- 1.3.3 Scientific Research
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Diabetic Retinopathy Screening Solution Growth Trends by Region
- 1.5.1 Global Diabetic Retinopathy Screening Solution Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Diabetic Retinopathy Screening Solution Market Size by Region (2021-2026)
- 1.5.3 Diabetic Retinopathy Screening Solution Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Diabetic Retinopathy Screening Solution Market Dynamics
- 2.1 Diabetic Retinopathy Screening Solution Industry Trends
- 2.2 Diabetic Retinopathy Screening Solution Industry Drivers
- 2.3 Diabetic Retinopathy Screening Solution Industry Opportunities and Challenges
- 2.4 Diabetic Retinopathy Screening Solution Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Diabetic Retinopathy Screening Solution Revenue by Company (2021-2026)
- 3.2 Global Diabetic Retinopathy Screening Solution Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Diabetic Retinopathy Screening Solution Key Company Head office and Area Served
- 3.4 Global Diabetic Retinopathy Screening Solution Company, Product Type & Application
- 3.5 Global Diabetic Retinopathy Screening Solution Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Diabetic Retinopathy Screening Solution Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Diabetic Retinopathy Screening Solution Players Market Share by Revenue in 2025
- 3.6.3 2025 Diabetic Retinopathy Screening Solution Tier 1, Tier 2, and Tier 3
4 Diabetic Retinopathy Screening Solution Market by Type
- 4.1 Global Diabetic Retinopathy Screening Solution Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Diabetic Retinopathy Screening Solution Market Size by Type (2021-2032)
- 4.3 Global Diabetic Retinopathy Screening Solution Market Size Share by Type (2021-2032)
5 Diabetic Retinopathy Screening Solution Market by Application
- 5.1 Global Diabetic Retinopathy Screening Solution Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Diabetic Retinopathy Screening Solution Market Size by Application (2021-2032)
- 5.3 Global Diabetic Retinopathy Screening Solution Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 RETINA-AI Health
- 6.1.1 RETINA-AI Health Company Information
- 6.1.2 RETINA-AI Health Business Overview
- 6.1.3 RETINA-AI Health Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 RETINA-AI Health Diabetic Retinopathy Screening Solution Product Portfolio
- 6.1.5 RETINA-AI Health Recent Developments
- 6.2 IRIS
- 6.2.1 IRIS Company Information
- 6.2.2 IRIS Business Overview
- 6.2.3 IRIS Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 IRIS Diabetic Retinopathy Screening Solution Product Portfolio
- 6.2.5 IRIS Recent Developments
- 6.3 Retina Labs
- 6.3.1 Retina Labs Company Information
- 6.3.2 Retina Labs Business Overview
- 6.3.3 Retina Labs Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Retina Labs Diabetic Retinopathy Screening Solution Product Portfolio
- 6.3.5 Retina Labs Recent Developments
- 6.4 CheckEye
- 6.4.1 CheckEye Company Information
- 6.4.2 CheckEye Business Overview
- 6.4.3 CheckEye Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 CheckEye Diabetic Retinopathy Screening Solution Product Portfolio
- 6.4.5 CheckEye Recent Developments
- 6.5 RetinaLyze
- 6.5.1 RetinaLyze Company Information
- 6.5.2 RetinaLyze Business Overview
- 6.5.3 RetinaLyze Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 RetinaLyze Diabetic Retinopathy Screening Solution Product Portfolio
- 6.5.5 RetinaLyze Recent Developments
- 6.6 NEC Software
- 6.6.1 NEC Software Company Information
- 6.6.2 NEC Software Business Overview
- 6.6.3 NEC Software Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 NEC Software Diabetic Retinopathy Screening Solution Product Portfolio
- 6.6.5 NEC Software Recent Developments
- 6.7 InHealth Intelligence
- 6.7.1 InHealth Intelligence Company Information
- 6.7.2 InHealth Intelligence Business Overview
- 6.7.3 InHealth Intelligence Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 InHealth Intelligence Diabetic Retinopathy Screening Solution Product Portfolio
- 6.7.5 InHealth Intelligence Recent Developments
- 6.8 RetinaRisk
- 6.8.1 RetinaRisk Company Information
- 6.8.2 RetinaRisk Business Overview
- 6.8.3 RetinaRisk Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 RetinaRisk Diabetic Retinopathy Screening Solution Product Portfolio
- 6.8.5 RetinaRisk Recent Developments
- 6.9 Thirona Retina
- 6.9.1 Thirona Retina Company Information
- 6.9.2 Thirona Retina Business Overview
- 6.9.3 Thirona Retina Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Thirona Retina Diabetic Retinopathy Screening Solution Product Portfolio
- 6.9.5 Thirona Retina Recent Developments
- 6.10 Synapxe
- 6.10.1 Synapxe Company Information
- 6.10.2 Synapxe Business Overview
- 6.10.3 Synapxe Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Synapxe Diabetic Retinopathy Screening Solution Product Portfolio
- 6.10.5 Synapxe Recent Developments
- 6.11 Eyenuk
- 6.11.1 Eyenuk Company Information
- 6.11.2 Eyenuk Business Overview
- 6.11.3 Eyenuk Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Eyenuk Diabetic Retinopathy Screening Solution Product Portfolio
- 6.11.5 Eyenuk Recent Developments
- 6.12 EyRIS (SELENA+)
- 6.12.1 EyRIS (SELENA+) Company Information
- 6.12.2 EyRIS (SELENA+) Business Overview
- 6.12.3 EyRIS (SELENA+) Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 EyRIS (SELENA+) Diabetic Retinopathy Screening Solution Product Portfolio
- 6.12.5 EyRIS (SELENA+) Recent Developments
- 6.13 Vistel
- 6.13.1 Vistel Company Information
- 6.13.2 Vistel Business Overview
- 6.13.3 Vistel Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Vistel Diabetic Retinopathy Screening Solution Product Portfolio
- 6.13.5 Vistel Recent Developments
7 North America
- 7.1 North America Diabetic Retinopathy Screening Solution Market Size (2021-2032)
- 7.2 North America Diabetic Retinopathy Screening Solution Market Size by Type
- 7.2.1 North America Diabetic Retinopathy Screening Solution Market Size by Type (2021-2026)
- 7.2.2 North America Diabetic Retinopathy Screening Solution Market Size by Type (2027-2032)
- 7.2.3 North America Diabetic Retinopathy Screening Solution Market Share by Type (2021-2032)
- 7.3 North America Diabetic Retinopathy Screening Solution Market Size by Application
- 7.3.1 North America Diabetic Retinopathy Screening Solution Market Size by Application (2021-2026)
- 7.3.2 North America Diabetic Retinopathy Screening Solution Market Size by Application (2027-2032)
- 7.3.3 North America Diabetic Retinopathy Screening Solution Market Share by Application (2021-2032)
- 7.4 North America Diabetic Retinopathy Screening Solution Market Size by Country
- 7.4.1 North America Diabetic Retinopathy Screening Solution Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Diabetic Retinopathy Screening Solution Market Size by Country (2021-2026)
- 7.4.3 North America Diabetic Retinopathy Screening Solution Market Size by Country (2027-2032)
- 7.4.4 North America Diabetic Retinopathy Screening Solution Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Diabetic Retinopathy Screening Solution Market Size (2021-2032)
- 8.2 Europe Diabetic Retinopathy Screening Solution Market Size by Type
- 8.2.1 Europe Diabetic Retinopathy Screening Solution Market Size by Type (2021-2026)
- 8.2.2 Europe Diabetic Retinopathy Screening Solution Market Size by Type (2027-2032)
- 8.2.3 Europe Diabetic Retinopathy Screening Solution Market Share by Type (2021-2032)
- 8.3 Europe Diabetic Retinopathy Screening Solution Market Size by Application
- 8.3.1 Europe Diabetic Retinopathy Screening Solution Market Size by Application (2021-2026)
- 8.3.2 Europe Diabetic Retinopathy Screening Solution Market Size by Application (2027-2032)
- 8.3.3 Europe Diabetic Retinopathy Screening Solution Market Share by Application (2021-2032)
- 8.4 Europe Diabetic Retinopathy Screening Solution Market Size by Country
- 8.4.1 Europe Diabetic Retinopathy Screening Solution Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Diabetic Retinopathy Screening Solution Market Size by Country (2021-2026)
- 8.4.3 Europe Diabetic Retinopathy Screening Solution Market Size by Country (2027-2032)
- 8.4.4 Europe Diabetic Retinopathy Screening Solution Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Diabetic Retinopathy Screening Solution Market Size (2021-2032)
- 9.2 China Diabetic Retinopathy Screening Solution Market Size by Type
- 9.2.1 China Diabetic Retinopathy Screening Solution Market Size by Type (2021-2026)
- 9.2.2 China Diabetic Retinopathy Screening Solution Market Size by Type (2027-2032)
- 9.2.3 China Diabetic Retinopathy Screening Solution Market Share by Type (2021-2032)
- 9.3 China Diabetic Retinopathy Screening Solution Market Size by Application
- 9.3.1 China Diabetic Retinopathy Screening Solution Market Size by Application (2021-2026)
- 9.3.2 China Diabetic Retinopathy Screening Solution Market Size by Application (2027-2032)
- 9.3.3 China Diabetic Retinopathy Screening Solution Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Diabetic Retinopathy Screening Solution Market Size (2021-2032)
- 10.2 Asia Diabetic Retinopathy Screening Solution Market Size by Type
- 10.2.1 Asia Diabetic Retinopathy Screening Solution Market Size by Type (2021-2026)
- 10.2.2 Asia Diabetic Retinopathy Screening Solution Market Size by Type (2027-2032)
- 10.2.3 Asia Diabetic Retinopathy Screening Solution Market Share by Type (2021-2032)
- 10.3 Asia Diabetic Retinopathy Screening Solution Market Size by Application
- 10.3.1 Asia Diabetic Retinopathy Screening Solution Market Size by Application (2021-2026)
- 10.3.2 Asia Diabetic Retinopathy Screening Solution Market Size by Application (2027-2032)
- 10.3.3 Asia Diabetic Retinopathy Screening Solution Market Share by Application (2021-2032)
- 10.4 Asia Diabetic Retinopathy Screening Solution Market Size by Country
- 10.4.1 Asia Diabetic Retinopathy Screening Solution Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Diabetic Retinopathy Screening Solution Market Size by Country (2021-2026)
- 10.4.3 Asia Diabetic Retinopathy Screening Solution Market Size by Country (2027-2032)
- 10.4.4 Asia Diabetic Retinopathy Screening Solution Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Diabetic Retinopathy Screening Solution Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Diabetic Retinopathy Screening Solution Market Size by Type
- 11.2.1 South America, Middle East & Africa Diabetic Retinopathy Screening Solution Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Diabetic Retinopathy Screening Solution Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Diabetic Retinopathy Screening Solution Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Diabetic Retinopathy Screening Solution Market Size by Application
- 11.3.1 South America, Middle East & Africa Diabetic Retinopathy Screening Solution Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Diabetic Retinopathy Screening Solution Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Diabetic Retinopathy Screening Solution Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Diabetic Retinopathy Screening Solution Market Size by Country
- 11.4.1 South America, Middle East & Africa Diabetic Retinopathy Screening Solution Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Diabetic Retinopathy Screening Solution Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Diabetic Retinopathy Screening Solution Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Diabetic Retinopathy Screening Solution Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst